Advertisement

Topics

Latest "Novella Clinical Resourcing" News Stories

06:49 EST 21st January 2019 | BioPortfolio

Here are the most relevant search results for "Novella Clinical Resourcing" found in our extensive news archives from over 250 global news sources.

More Information about Novella Clinical Resourcing on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Novella Clinical Resourcing for you to read. Along with our medical data and news we also list Novella Clinical Resourcing Clinical Trials, which are updated daily. BioPortfolio also has a large database of Novella Clinical Resourcing Companies for you to search.

Showing "Novella Clinical Resourcing" News Articles 1–25 of 14,000+

Monday 21st January 2019

VentureMed starts Swiss enrollment for FLEX vessel preparation system

VentureMed said the clinical study intends to evaluate lumen patency at twelve months obtained by preparation of vessels with the FLEX Vessel Preparation System prior to conventional endovascular The post VentureMed starts Swiss enrollment for FLEX vessel preparation system appeared first on Compelo Medical Devices.


Planning for clinical trials in a post-Brexit world

Bruno Speder, Head of Clinical Regulatory Affairs and Consultancy at SGS Clinical Research, discusses the potential implications of Brexit on clinical trials and the development of new medicines

How new tests might help find treatments for cancers with no known origin

Science blog Where a cancer first grows in the body plays a huge part in choosing how to treat it. But for 2 in every 100 cancers diagnosed in the UK each year, doctors can’t find that original tumour. These rare cases are called carcinoma of unknown primary (CUP). And they pose a huge challenge when it comes to selecting treatment. The first signs of cancer that lead to a diagnosis of CUP us...


US FDA issues guidance for clinical trial endpoints for approval of cancer drugs and biologics

The US FDA has issued the final guidance on clinical trial endpoints for the approval of cancer drugs and biologics. This according to the industry is a major benefit for the companies that export products to both the

Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Advanced Hepatocellular Carcinoma in Frontiers in Oncology

Press Release 21 January 2019 Immunicum AB (publ) Announces Publication of Phase  I/II Clinical Trial Results of Ilixadencel in Advanced Hepatocellular Carcinoma in Frontiers in Oncology Immunicum AB (publ; IMMU.ST) announced today that the final data analysis from the exploratory clinical study of ilixadencel in patients with advanced hepatocellular carcinoma (HCC) has been pub...

Gore Introduces GORE® TAG® Conformable Thoracic Stent Graft with Reduced Profiles in Europe

Reduced profiles on most commonly used sizes allow the device to be introduced through a smaller sheath while maintaining the state-of-the-art conformable design W. L. Gore & Associates, Inc. (Gore) today introduced reduced profiles for the most commonly used diameters of the GORE® TAG® Conformable Thoracic Stent

Lilly’s second immune-oncology candidate using Zymeworks’ Azymetric platform to start clinical trials

In accordance with Zymeworks’ 2014 licensing and collaboration agreement with Lilly, Zymeworks will receive a milestone payment of US$8.0 million for Lilly’s submission of an IND application for The post Lilly’s second immune-oncology candidate using Zymeworks’ Azymetric platform to start clinical trials appeared first on Pharmaceutical Business review.

Neuroimmunology Drug Development [Report Updated: 17122018] Prices from USD $7995

Neuroimmunology Drug DevelopmentSummaryNeuroimmunology is expected to be an area that will witness strong growth in the future due to factors such as deeper understanding of the underlying disease pathology, advancements in neurogenetics, and potential of these drugs that can contribute to targeted therapy. Pipeline drugs targeting a number of neurology indications are being developed; however, th...

Biomarkers and Companion Diagnostics in Oncology [Report Updated: 17122018] Prices from USD $7995

Biomarkers and Companion Diagnostics in OncologySummaryA biomarker is a defined molecular characteristic, for example a genetic mutation, that can tell a physician more about a patient's disease state, or how they might respond to treatment. Predictive biomarkers indicate how likely a patient is to respond to a treatment, and are used in clinical decision making. In some cases, a patient must poss...

Global Rheumatic Disorders Drugs Market to 2024 Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry [Report Updated: 01012019] Prices from USD $4995

Global Rheumatic Disorders Drugs Market to 2024 Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent ExpirySummaryThe rheumatic disorder therapy area is multidisciplinary in nature and encompasses conditions that affect joints, connective tissue, ligaments, tendons, cartilage, bone and muscle and which are characterized by chronic pain and a consequen...

Global Women's Health Drugs Market to 2024 Influx of New Products Including Orilissa, Relugolix and Bremelanotide to Diversify Landscape and Drive Growth [Report Updated: 01012019] Prices from USD $4995

Global Women's Health Drugs Market to 2024 Influx of New Products Including Orilissa, Relugolix and Bremelanotide to Diversify Landscape and Drive GrowthSummaryThe women's health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many o...

Global Clinical Trials Current Trends and Recent Advancement [Report Updated: 01012019] Prices from USD $2995

Global Clinical Trials Current Trends and Recent AdvancementSummaryGBI Research's latest report, Global Clinical Trials Current Trends and Recent Advancement, provides an indepth assessment of the current trends in the number of clinical trials globally, Top 10 therapy area, geography wise clinical trials, YOY clinical trials in top 10 therapy area.Major sponsor are focusing on oncology as Cance...

Emerging Gene Therapies Trends within the Technological, Clinical, Regulatory and Competitive Landscape [Report Updated: 03012019] Prices from USD $2995

Emerging Gene Therapies Trends within the Technological, Clinical, Regulatory and Competitive LandscapeSummaryGBI Research's latest report Emerging Gene Therapies Trends within the Technological, Clinical, Regulatory and Competitive Landscape provides a comprehensive overview of the emerging gene therapy market. The report discusses gene therapy and the technology behind gene editing, outlining ...

PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream Targets [Report Updated: 01072018] Prices from USD $2995

PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream TargetsSummaryGBI Research's latest report, PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream Targets, provides a comprehensive assessment of the market...

Allergic Asthma Global Clinical Trials Review, H2, 2018 [Report Updated: 25102018] Prices from USD $2500

Allergic Asthma Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Allergic Asthma Global Clinical Trials Review, H2, 2018" provides an overview of Allergic Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic Asthma. Report includes an overview of trial numbers and their average enrollment in top countries c...

Sunday 20th January 2019

Pipeline Watch: Phase II Results With ZGN-1061 And OMS721

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...   

Early studies and recent clinical trials on nerve growth factor

Nerve growth factor has been playing an important role in development of adult neurobiology. This is because of the regulatory functions that it possesses on survival, growth and differentiation of nerve cells in both of the central and peripheral nervous systems.

SanBio: Addition of a Cerebral Hemorrhage Program for SB623 Regenerative Cell Medicine

At a meeting held today, the Board of Directors of SanBio Co., Ltd. (hereinafter, the “Company”) resolved to add a program for treatment of chronic motor deficit from cerebral hemorrhage as a new indication for SB623, a regenerative cell medicine developed by the Group. (Hereinafter, the “Group” refers to two companies, SanBio Co., Ltd., and SanBio...

China’s clinical trial shake-up

As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location

Acute Bronchitis Global Clinical Trials Review, H2, 2018 [Report Updated: 25102018] Prices from USD $2500

Acute Bronchitis Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Acute Bronchitis Global Clinical Trials Review, H2, 2018" provides an overview of Acute Bronchitis clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Bronchitis. Report includes an overview of trial numbers and their average enrollment in top countri...

Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2018 [Report Updated: 25102018] Prices from USD $2500

Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Acute Spinal Cord Injury Global Clinical Trials Review, H2, 2018" provides an overview of Acute Spinal Cord Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Spinal Cord Injury. Report includes an overview of trial numbers and their a...

Dr. Laurie Nakahira Joins Santa Clara Family Health Plan as Chief Medical Officer

SAN JOSE, Calif. (PRWEB) January 19, 2019 With more than 20 years in clinical practice and management, Dr. Nakahira is responsible for ensuring the availability, quality and delivery of health care services to SCFHP members via medical oversight of operations and activities of Utilization Man...

Saturday 19th January 2019

Therachon gets US FDA orphan drug status for apraglutide for short bowel syndrome treatment

Therachon AG, a clinical─stage biotechnology company focused on the discovery, development and commercialization of innovative treatments for serious rare conditions, announced that the US Food and Drug

Anterior Uveitis Global Clinical Trials Review, H2, 2018 [Report Updated: 31102018] Prices from USD $2500

Anterior Uveitis Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Anterior Uveitis Global Clinical Trials Review, H2, 2018" provides an overview of Anterior Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials on Anterior Uveitis. Report includes an overview of trial numbers and their average enrollment in top countri...

Wilms' Tumor Nephroblastoma Global Clinical Trials Review, H2, 2018 [Report Updated: 25102018] Prices from USD $2500

Wilms' Tumor Nephroblastoma Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Wilms' Tumor Nephroblastoma Global Clinical Trials Review, H2, 2018" provides an overview of Wilms' Tumor Nephroblastoma clinical trials scenario. This report provides top line data relating to the clinical trials on Wilms' Tumor Nephroblastoma. Report includes an overview of trial numbers...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks